The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Open label, phase II study of axitinib, a selective inhibitor of vascular endothelial growth factor receptors, in patients with stage III malignant melanoma.

Eric  Zhuang

No Relationships to Disclose

James G.  Jakowatz

No Relationships to Disclose

Maki  Yamamoto

Speakers' Bureau - Amgen

Travel, Accommodations, Expenses - Amgen

John P.  Fruehauf

Leadership - 300 Cells

Consulting or Advisory Role - Novartis

Speakers' Bureau - Genentech/Roche; Merck; Novartis; Sanofi

Travel, Accommodations, Expenses - Genzyme; Merck Sharp & Dohme; Novartis